Celldex Therapeutics, Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for CLDX, updated each market day.
CLDX AI Sentiment
AI sees no strong directional signal for Celldex Therapeutics, Inc stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Celldex Therapeutics, Inc
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Sector
Exchange
Market Cap
$3,061,081,157
Cap Tier
Employees
198
Headquarters
HAMPTON, NJ
Listed Since
May 15, 1986
Website
CLDX Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CLDX Volatility
Celldex Therapeutics, Inc has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
